Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "viral-induced radicals" refers to a biological phenomenon, specifically the production of free radicals (including reactive oxygen species [ROS] and reactive nitrogen species [RNS]) that are generated in host cells in response to viral infection. These are byproducts of cellular processes triggered during viral pathogenesis, involving pathways like NADPH oxidase (NOX/DUOX) family enzymes and nitric oxide (•NO) synthase, leading to oxidative stress. It is not a single, discrete molecular target, receptor, enzyme, transporter, or other identifiable drug target. Therefore, it cannot be characterized using a structured framework for therapeutic targets. Research into therapeutic approaches related to this phenomenon focuses on targeting upstream regulators or downstream effects, such as ferroptosis modulators, iron metabolism pathways, or ROS-generating enzymes, rather than the 'radicals' themselves.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral-induced radicals.